Biofrontera
BFRIW
6 hedge funds and large institutions have $236K invested in Biofrontera in 2022 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 1 increasing their positions, 0 reducing their positions, and 0 closing their positions.
200% more funds holding
Funds holding: 2 → 6 (+4)
0.39% less ownership
Funds ownership: 2.34% → 1.94% (-0.39%)
40% less capital invested
Capital invested by funds: $396K → $236K (-$160K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$28.8K |
| 2 |
WAM
Warberg Asset Management
Winnetka,
Illinois
|
+$14.8K |
| 3 |
CS
Clear Street
New York
|
+$14.1K |
| 4 |
BA
Bard Associates
Chicago,
Illinois
|
+$5.51K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$4.25K |
Top Sellers
BFRIW Hedge Fund Activity: Q2 2022 in Review
6 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in Biofrontera (BFRIW) for Q2 2022, worth a combined $236K — down 40% from $396K a quarter earlier.
Buyers outnumbered sellers: 4 funds opened new BFRIW positions and 0 closed out — a net gain of 4 holders — while 1 added to existing stakes and 0 trimmed.
The largest buyer was Susquehanna International Group, opening a new position worth an estimated $28.8K.
- 6 institutional investors held Biofrontera (BFRIW) as of Q2 2022, up from 2 in Q1 2022.
- Funds reported $236K of Biofrontera stock for Q2 2022, down 40% quarter-over-quarter.
- 4 funds opened new Biofrontera positions in Q2 2022 and 0 closed out, a net change of +4 holders.
- The largest Biofrontera buyer in Q2 2022 was Susquehanna International Group, an estimated $28.8K added.
Based on aggregated 13F filings for Q2 2022.